about
Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic ReviewDisparities in hospitalizations among HIV positive individuals for Native Hawaiians and Asians compared to Whites in Hawai'i.High rates of Native Hawaiian and older Japanese adults hospitalized with dementia in Hawai'i.Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral TherapySymptoms of Autonomic Dysfunction in Human Immunodeficiency Virus.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Aerobic fitness levels and validation of a non exercise VO2max prediction equation for HIV-infected patients on HAART.Early Childhood Vision Screening in Hawai'i Utilizing a Hand-Held Screener.The Impact of Depressive Symptoms on Neuropsychological Performance Tests in HIV-Infected Individuals: A Study of the Hawaii Aging with HIV Cohort.Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy.Frailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study.High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy.Poorer neuropsychological performance increases risk for social services among HIV-infected individuals.Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors.Reduced functional connectivity between ventromedial prefrontal cortex and insula relates to longer corrected QT interval in HIV+ and HIV- individuals.Feasibility and potential role of ferumoxytol-enhanced neuroimaging in HIV-associated neurocognitive disorder.Plasminogen Activator Inhibitor-1 Predicts Negative Alterations in Whole-Body Insulin Sensitivity in Chronic HIV Infection.HIV Patient Systemic Mitochondrial Respiration Improves with Exercise.Rates of autonomic dysfunction in HIV patients receiving antiretroviral therapyInflammation and Albuminuria in HIV-infected Patients Receiving Combination Antiretroviral Therapy.Symptoms of Autonomic Dysfunction in HIV-Infected Stable Patients on Combined Antiretroviral Therapy.Seasonal Variation of 25-Hydroxyvitamin D Levels in HIV-Infected Patients in Hawai‘i.Reply to "The insular cortex and QTc interval in HIV+ and HIV- individuals: Is there an effect of sympathetic nervous system activity?"Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions1.Red blood cell distribution width as an easily measurable biomarker of persistent inflammation and T cell dysregulation in antiretrovirally treated HIV-infected adultsAutonomic Function is Associated with Fitness Level in HIV-Infected IndividualsCenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapyDetailed 3-dimensional body shape features predict body composition, blood metabolites, and functional strength: the Shape Up! studiesRelationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal ThicknessFrailty is associated with insulin resistance in chronic HIVCenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expressionChildren and Adolescents' Anthropometrics Body Composition from 3-D Optical Surface ScansShort Communication: Metformin Reduces CD4 T Cell Exhaustion in HIV-Infected Adults on Suppressive Antiretroviral TherapyLower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV InfectionPD-1+ and TIGIT+ CD4 T Cells Are Associated With Coronary Artery Calcium Progression in HIV-Infected Treated AdultsSubcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected PatientsSleep and neuropsychological performance in HIV+ subjects on efavirenz-based therapy and response to switch in therapyThe Effects of Extended Release Niacin on Lipoprotein Sub-Particle Concentrations in HIV-Infected Patients
P50
Q28080289-EE8BD103-8606-461C-9D82-22728F90D839Q34372703-1A269B78-E60D-4F0D-8158-3F69A493AA02Q34989758-D64B924A-4B2F-4F5D-9E1F-7CDBF95EEB5FQ35036648-D79111A4-C98B-490B-83E1-FA41766192A4Q35921028-21414B9F-3274-48F3-8AD5-7F415B04799FQ35935648-732A9B56-2F5A-4750-9B0E-C2CE0F938D70Q35994939-C10B5A68-6C2A-4A2A-8545-3C8FDDF9F16FQ36061343-FE1F2483-0A49-4D35-89F7-9F57993C9A54Q36081617-A8ABA496-A652-4684-949E-84C276927323Q36305528-4A44E82A-C3F2-467C-AE91-C1EF86226B0CQ37024994-FE17D44A-8556-416A-94C5-40B8E252990CQ37150657-B6214E61-15DE-468F-B71C-F47BA5501C11Q37313204-9F5CC5B2-6ADC-4D80-8163-D5A0412DC992Q37384202-93113887-BABB-4071-AC29-9111F776A93BQ37414290-DB9A0736-8A27-455E-B8A0-CB5EAA5E930EQ37543248-3D57D5C4-29DA-432E-ACE0-95591AC8574FQ39234840-A00A4D53-07F7-4E24-8779-66231B7258ADQ39331854-9A4C96E8-52C2-4868-B5BC-FB5B751F36C0Q39598436-3016B464-92A5-467A-BB7F-C4C65C587F31Q40228207-8E9043B2-DD2F-4A61-8E95-6EDAEBC39DEBQ42717921-2A78D474-E7B6-4F94-BC09-F35B2CD9B202Q46732013-253E2149-CCA0-4327-9F81-21BB00D1DE72Q46732229-617308C1-3DD5-464E-BE48-87106C1C30EAQ46781407-88A38455-FE83-4B0B-B8DF-5312729E06A1Q49709553-BAAC10EA-28AA-44E0-9350-09D60814C483Q52376403-2E8C6FF5-9EF7-4699-B99F-A2FD942565A3Q59351192-D05F7D8F-D247-4695-B829-869176051B22Q85653782-22E8B5CB-7C2E-4ABF-9050-12CEB983CC3FQ89513511-31E04BF2-C372-4923-AB79-7E4F7970765CQ90277709-32649548-BC57-4B46-ABAC-FCB7053EAEB4Q90529615-2D5E8537-6B07-4AAA-B137-8C42BDC06FE6Q90707035-5CB58475-426E-44ED-A87F-7F67C1EBA06AQ90833804-5238E51E-9B9A-4CEC-BE05-AC2278DBE900Q91121691-178DE313-B268-4175-8812-26F23CD5BB35Q91300223-3F73244A-A222-4E6C-AB8F-F51B48009388Q92072174-F74519F9-0ACD-4F65-8F85-38BA91D55F86Q92325712-64684C04-6ED2-4AE1-B7F4-038C22478BF4Q92587042-907AB164-D167-4A99-BC14-C47EA3563EADQ93207608-ED8BE5D1-2858-467E-B1B2-5F9DC8CD5E32Q93589331-941BC831-CCD8-4BB3-9161-99394F882B97
P50
description
investigador
@es
researcher
@en
name
Dominic C Chow
@en
type
label
Dominic C Chow
@en
prefLabel
Dominic C Chow
@en
P31
P496
0000-0001-7395-038X